🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well the combination of botensilimab, balst...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06575725
The goal of this study is to see if the drug balstilimab is safe and effect...
Status
Recruiting
Location
Hematology Center named after prof. R. Yeolyan
Start Date
2023-09-01
Trial ID
NCT05891821
Treatments Being Tested
The researchers are doing this study to find out whether the combination of...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-11-07
Trial ID
NCT07227636
Treatments Being Tested
This is an open-label, non-randomized, single-institution, single arm Phase...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2020-01-28
Trial ID
NCT04028063
Treatments Being Tested
This study aims to leverage this unique property of HPV+ OPC to detect poss...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-18
Trial ID
NCT05363709
Treatments Being Tested
This study is a randomized, open label, multicenter Phase II trial to evalu...
Status
Suspended
Location
University of California San Diego
Start Date
2023-09-25
Trial ID
NCT05928806
Treatments Being Tested
The goal of this clinical trial is to learn whether the combination of bals...
Status
Recruiting
Location
Scripps Clinic Torrey Pines
Start Date
2026-06-10
Trial ID
NCT07550088
Treatments Being Tested
The goal of this study is to see if the combination of immunotherapy agents...
Status
Active Not Recruiting
Location
Hematology Center named after prof. R. Yeolyan
Start Date
2024-06-13
Trial ID
NCT06322108
Treatments Being Tested
This is an open-label, Phase 1, 2-part trial to determine recommended phase...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2022-07-19
Trial ID
NCT05377528
Treatments Being Tested
The purpose of this study is to determine the optimal dose of AGEN2373 that...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2025-05-27
Trial ID
NCT06782932
Treatments Being Tested